{
    "id": "a03bd013-b2d8-4fa2-b4e0-1a109a9d6c6e",
    "indications": "amlodipine benazepril hydrochloride capsule , combination capsule amlodipine , dihydropyridine calcium channel blocker ( dhp ccb ) benazepril , angiotensin converting-enzyme ( ace ) inhibitor . amlodipine benazepril hydrochloride capsule , indicated treatment hypertension patients adequately controlled monotherapy either agent ( 1 ) .",
    "contraindications": "usual starting dose 2.5/10 mg. ( 2.1 ) may used add-on therapy patients adequately controlled either dihydropyridine calcium channel blocker ace inhibitor . ( 2.2 ) patients experience edema amlodipine may switched amlodipine benazepril hydrochloride capsules , containing lower dose amlodipine . ( 2.1 )",
    "warningsAndPrecautions": "product : 50090-6185 ndc : 50090-6185-0 30 capsule bottle ndc : 50090-6185-1 90 capsule bottle",
    "adverseReactions": "coadminister aliskiren ace inhibitors , including amlodipine benazepril hydrochloride , patients diabetes . ( 4 ) amlodipine benazepril hydrochloride contraindicated patients history angioedema patients hypersensitive benazepril amlodipine . ( 4 ) amlodipine benazepril hydrochloride contraindicated combination neprilysin inhibitor ( e.g . , sacubitril ) . administer amlodipine benazepril hydrochloride capsules within 36 hours switching neprilysin inhibitor , e.g . , sacubitril/valsartan . ( 5.1 )",
    "ingredients": [
        {
            "name": "AMLODIPINE BESYLATE",
            "code": "864V2Q084H"
        },
        {
            "name": "BENAZEPRIL HYDROCHLORIDE",
            "code": "N1SN99T69T"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L"
        },
        {
            "name": "SILICA",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "CROSPOVIDONE (120 .MU.M)",
            "code": "68401960MK"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "POVIDONE, UNSPECIFIED",
            "code": "FZ989GH94E"
        },
        {
            "name": "POTASSIUM HYDROXIDE",
            "code": "WZH3C48M4T"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "CI 77499",
            "code": "XM0M87F357"
        },
        {
            "name": "HEMATITE",
            "code": "1K09F3G675"
        }
    ],
    "organization": "A-S Medication Solutions",
    "name": "Amlodipine Besylate and Benazepril Hydrochloride",
    "effectiveTime": "20250506",
    "indications_original": "Amlodipine and benazepril hydrochloride capsule, is a combination capsule of amlodipine, a dihydropyridine calcium channel blocker (DHP CCB) and benazepril, an angiotensin converting-enzyme (ACE) inhibitor. Amlodipine and benazepril hydrochloride capsule, is indicated for the treatment of hypertension in patients not adequately controlled on monotherapy with either agent ( 1 ).",
    "contraindications_original": "Usual starting dose is 2.5/10 mg. ( 2.1 ) May be used as add-on therapy for patients not adequately      controlled with either a dihydropyridine calcium channel blocker or an ACE      inhibitor. ( 2.2 ) Patients who experience edema with amlodipine may be      switched to amlodipine and benazepril hydrochloride capsules, Â containing      a lower dose of amlodipine. ( 2.1 )",
    "warningsAndPrecautions_original": "Product:    50090-6185\n                  NDC:    50090-6185-0   30 CAPSULE in a BOTTLE\n                  NDC:    50090-6185-1   90 CAPSULE in a BOTTLE",
    "adverseReactions_original": "Do not coadminister aliskiren      with ACE inhibitors, including amlodipine and benazepril hydrochloride, in      patients with diabetes. ( 4 ) Amlodipine and      benazepril hydrochloride is contraindicated in patients with a history of      angioedema or patients who are hypersensitive to benazepril or to      amlodipine. ( 4 ) Amlodipine and      benazepril hydrochloride is contraindicated in combination with a      neprilysin inhibitor (e.g., sacubitril). Do not administer amlodipine and      benazepril hydrochloride capsules within 36 hours of switching to or from      a neprilysin inhibitor, e.g., sacubitril/valsartan. ( 5.1 )"
}